Alnylam Tanks After Drug Trial Fatality; Fitbit Breaks Above Key Trendline

Anlylam Pharmaceuticals suspended a clinical trial for its rare blood disease drug after a patient death

Sep 7, 2017 at 3:16 PM
facebook X logo linkedin


U.S. stocks are mixed this afternoon, with traders taking a cautious approach as Hurricane Irma charts an uncertain path toward Florida. Among the stocks in the spotlight today are biopharmaceutical company Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), bookseller Barnes & Noble, Inc. (NYSE:BKS), and fitness device maker Fitbit Inc (NYSE:FIT). Here's a quick look at what's moving shares of ALNY, BKS, and FIT.

Alnylam Stock Suffers After Drug Setback

Alnylam Pharmaceuticals stock is down 13.9% to trade at $74.08, after a patient's death prompted the drugmaker to stop administering fiturisan, a bleeding disorder treatment, in a clinical trial. This comes a year after Alnylam discontinued a drug for a rare hereditary disease over patient safety concerns. The company expects to resume clinical studies for the suspended drug, named fitusiran, by late 2017. Still, the biotech stock is up roughly 98% year-to-date after hitting an annual high of $89.45 last Friday.

Shorts are likely cheering today's decline, as short interest represents 12% of ALNY's total available float. At the equity's average daily trading volume, it would take more than two weeks to cover these shorted shares.

Barnes & Noble Stock Falls After Earnings

A wider-than-expected fiscal first-quarter loss has Barnes & Noble stock down 11.1% to trade at $6.98. The book retailer cited lackluster quarterly sales of its Nook reading tablet, which resulted from lower promotional activity. BKS shares have lost roughly 37% this year, and hit a five-year low of $6.25 on June 21, with recent breakout attempts contained by its 120-day moving average.

Option traders on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) have upped the bearish ante of late. BKS sports a 10-day put/call volume of 8.43, which ranks in the 94th percentile of its annual range. In other words, options players have bought more than eight times as many puts as calls on BKS in the past two weeks.

Fitbit Stock Soars on Dexcom Collaboration

Just over a week after Fitbit launched its Iconic smartwatch, the company announced its plan to collaborate with Dexcom to develop products to help people better manage their diabetes. The companies call it the Continuous Glucose Monitoring (CGM) experience, and hope to make products available to the public next year.

As a result, FIT shares are trading 11.9% higher at $6.62. Today's jump sent FIT shares to an intraday high of $6.78 -- territory the wearable tech stock hasn't seen since early May. What's more, FIT shares are now poised to close above their 200-day moving average for the first time in a year.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI